Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Raloxifene and Cholecalciferol PK Study
NCT02654093Phase 1Completed
- Sponsor
- Alvogen
- Start
- Jan 2016
- Primary completion
- Mar 2016
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of raloxifene and vitamin d in osteoporosis, sponsored by Alvogen. Started Jan 2016; status: completed.
02
Drugs
raloxifenevitamin d
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT02654093.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02654093.